Phathom Pharmaceuticals Inc. Revenue 2022–2025
Phathom Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2022 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Phathom Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 58.3 M, a 104.43% increase year-over-year.
- Phathom Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 175.8 M, a 587.15% increase year-over-year.
- Phathom Pharmaceuticals Inc. annual revenue for 2025 was 175.1 M, a 216.93% increase from 2024.
- Phathom Pharmaceuticals Inc. annual revenue for 2024 was 55.3 M, a 8001.47% increase from 2023.
- Phathom Pharmaceuticals Inc. annual revenue for 2023 was 682000.
- Phathom Pharmaceuticals Inc. annual revenue for 2022 was 0.
Phathom Pharmaceuticals Inc. (PHAT) — Frequently Asked Questions
Phathom Pharmaceuticals Inc. (PHAT) is a publicly traded US company. It has a market capitalization of $716M. In fiscal 2025 it reported revenue of $175M and net income of -$221M. Explore PHAT's stock price, financial statements, earnings history, margins and key ratios below.
What is Phathom Pharmaceuticals Inc.'s market cap?
Phathom Pharmaceuticals Inc. (PHAT) has a market capitalization of $716M.
What is the PHAT stock price?
PHAT trades at $9.82.
How much revenue does Phathom Pharmaceuticals Inc. make?
Phathom Pharmaceuticals Inc. reported revenue of $175M in fiscal 2025.
Is PHAT profitable?
In fiscal 2025, Phathom Pharmaceuticals Inc. reported net income of -$221M.